Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Overweight × Exenatide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 4 Sexual Infantilism 3 Polycystic Ovary Syndrome 2 Craniopharyngioma 2 Weight Loss 1 Overweight 1 Fatty Liver 1 Diabetes Mellitus, Type 1 1

Interventions

sultamicillin 1 licogliflozin 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Sugars 1 Naltrexone 1 Flutamide 1 Exenatide 1 Ethinyl Estradiol 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01484873 2017-03-03

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Vanderbilt University Medical Center

Phase 2 Completed

10 enrolled 15 charts

Craniopharyngioma, Obesity, Sexual Infantilism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡